Transplantation Immunology Flashcards
what is graft rejection
inflammatory reaction that is the result of an adaptive immune response
define autologous graph
a graph transplanted from individual to the same individual
define syngeneic graft
a graft transplanted between two genetically identical individuals
define allogenic graft (or allograft) and alloantigens
graft transplanted between two genetically different individuals of the same species
alloantigens= the molecules that are recognized as foreign on the allografts
define xenogeneic graft (xenograft)
a graft transplanted between individuals of different species
the lymphocytes/antibodies that react to allografts/xenografts are described as being
alloreactive or xenoreactive
what are the antigens that stimulate adaptive immune response against allographs (responsible for for strong/rapid rejections)
histocompatibility proteins/molecules (or HLA)
->encoded by polymorphic genes that differ among individuals
what are the basic rules of transplantation immunology (4)
- cells/organs transplanted b/w genetically identical individuals are never rejected
- cells/organs transplanted b/w genetically different individuals are always rejected
- the offspring of a mating b/w two different inbred strains of an animal will not reject graphs from either parent (not true with BM transplants)
- a graft from the offspring of a mating of two different inbred strains will be rejected by either parent
the direct and indirect pathways
the different ways that allogenic MHC molecules on a graft can be presented for recognition by the recipient’s T cells (both are an initial step to allograft rejection)
direct recognition of alloantigens: T cells of a graft recipient recognize intact, unprocessed MHC molecules in the graft
indirect: recipient’s T cells recognize graft MHC molecules only in the context of of the recipient’s self MHC molecules on APCs
blocking what costimulator is a therapeutic strategy for inhibiting graft rejection in humans
B-7 molecules on APCs
what is the mixed lymphocyte reaction ?
the response of alloreactive T cells to foreign MHC molecules
- model of graft rejection
- establish the role of class 1 (for CD8+) and class 2 MHC (for CD4+) molecules (alloantigens)
- both CD4+ and CD8+ T cells from donor X react to donor T APC that has both MHC class 1 and 2 molecules
how do alloreactive CD4+ and CD8+ T cells activated by graft alloantigens cause rejection ?
CD4+: differentiate into cytokine producing effector cells that damage grafts by cytokine-mediated inflammation, similar to a delayed type hyper-sensitivity reaction CD8+: differentiate into CTLs which kill cells in the graft that express the allogeneic class 1 MHC molecules. they also secret inflammatory cytokines which can contribute to graft damage
what are the only T cells that can cause killing of the graft cells
cytotoxic T lymphocytes that are generated by direct allorecognition
(the other T cells will not be able to kill the graft cells because they are self MHC restricted and the graft cells dont express self MHC alleles displaying allogeneic peptides
activation of alloreactive B cells
is an example of indirect presentation of alloantigens
->The alloreactive antibodies produced in graft recipients engage the same mechanisms that antibodies use to combat infections
-the antigens most frequently recognized by by alloantibodies are donor HLA including MHC class 1 and 2 proteins
(mostly targeted at the graft vasculature bc the the HLA antigens are expressed on endothelial cell)
-activates neutrophils, macrophages and NK cells through the Fc receptor binding
hyperacute rejection
characterized by thrombotic occlusion (blood vessel blockage) of the graft vasculature that begins within mins to hours after host blood vessels are anastomosed to graft vessels
- mediated by preexisting antibodies in the host circulation that bind to donor endothelial antigens causing platelet adhesion and complement activation, endothelial damage, inflammation and thrombosis
- (now usually IgG antibodies that are directed against protein alloantigens such as donor MHC molecules)